Didn’t see the word “vaccine” anywhere in the article and I read it twice.
Wonder if they’re trying to prepare the public for something?
Don’t most of the patients with severe CoupFlu have preexisting conditions?
Maybe it’s not the CoupFlu.
Anecdotal to be sure, my friend was in the hospital over Christmas with Covid. She now has lung polyps and a hyper dense kidney. Neither of which she had pre covid.
I-RECOVER Protocol for Long Haul COVID Syndrome
https://covid19criticalcare.com/covid-19-protocols/i-recover-protocol/
From link (go to link to see protocol chart):
The Long Haul COVID Syndrome (LHCS) is an often debilitating syndrome characterized by a multitude of symptoms such as prolonged malaise, headaches, generalized fatigue, sleep difficulties, smell disorder, decreased appetite, painful joints, dyspnea, chest pain and cognitive dysfunction. The incidence of symptoms after COVID varies from as low as 10% to as high as 80%. LHCS is not only seen after the COVID infection but it is being observed in some people that have received vaccines (likely due to monocyte activation by the spike protein from the vaccine). A puzzling feature of the LHCS syndrome is that it is not predicted by initial disease severity; post-COVID-19 frequently affects mild-to-moderate cases and younger adults that did not require respiratory support or intensive care.
The symptom set of LHCS in the majority of cases is very similar to the chronic inflammatory response syndrome (CIRS)/ myalgic encephalomyelitis/chronic fatigue syndrome, although in LHCS, symptoms tend to improve slowly in the majority of the cases. Furthermore, the similarity between the mast cell activation syndrome and LHCS has been observed, and many consider post-COVID to be a variant of the mast cell activation syndrome. The LHCS syndrome is highly heterogenous and likely results from a variety of pathogenetic mechanisms. Furthermore, it is likely that delayed treatment (with ivermectin) in the early symptomatic phase will result in a high viral load, which increases the risk and severity of LHCS.
Although numerous reports describe the epidemiology and clinical features of LHCS, studies evaluating treatment options are glaringly sparse. Indeed, the NICE guideline for managing the long-term effects of COVID-19 provide no specific pharmacologic treatment recommendations.
Given the lack of available treatment recommendations in the setting of large numbers of patients suffering with this disorder globally, the FLCCC developed the I-RECOVER protocol in collaboration with a number of expert clinicians including Dr. Mobeen Syed, Dr. Ram Yogendra, Dr. Bruce Patterson, and Dr. Tina Peers. Although our varied yet often overlapping treatment approaches were initially empiric, while based on both preliminary investigations into and prevailing theoretical pathophysiologic mechanisms of LHCS, the consistently positive clinical responses observed, often profound and sustained, led the collaboration to form the consensus protocol below. As with all FLCCC protocols, we must emphasize that multiple aspects of the protocol may change as scientific data and clinical experience in this condition evolve, thus it is important to check back frequently or join the FLCCC Alliance to receive notification of any protocol changes.
16 June: Business Insider: China’s COVID-19 vaccines are being called into question after infections surged in countries using Chinese shots
by Marianne Guenot
https://www.msn.com/en-au/news/world/china-s-covid-19-vaccines-are-being-called-into-question-after-infections-surged-in-countries-using-chinese-shots/ar-AAL6Pjb?ocid=msedgntp
Well, if TPTB had not outlawed prophylactic early intervention to prevent people from getting so sick, there just might not be all these problems.
I had a cold in 1985. It lingered. Turned into bronchitis. In 2016, I found I had lung damage and scar tissue from that.
The illnesses we have can often have long-lasting effects.
I’m curious what percent of these individuals also received the vaccine? I’m not saying there’s a connection, because of course I don’t know, but I do find it odd that they gave lots of information, but not that piece. Are they not tracking that or just not reporting it? We should be looking at absolutely every possible variable so that we can be figuring out what is going on and how we can minimize these conditions.
How many of the 23% were offered ivermectin by their physician or own accord? Probably less than a half percent of them. SAD!
Me no believe.
bookmark
Missing from the article was the split by gender. A lot of the symptoms sound similar to autoimmune diseases found predominantly in women
Neural symptoms, palmitoylethanolamide, an anti-neuroinflammatory. It prevents microglia polarization. Took it during a bout of Covid (verified by antigen and PCR testing) and never had a problem. It is great for neuropathy, autism (a neuroinflammatory disorder), brain fog, etc. Visit ncbi.nlm.nih.gov and key in palmitoylethanolamide and neuroinflammation.
Que the ‘Why are so many Freepers antivax crowd’
I am sure I had COVID-18 in March 2019. Got mild pneumonia from it and joint pains that persisted for 2-3 months.
-—”Patient 0”
People who have had COVID are not guaranteed good health afterwards — stuff happens, especially as we get older.
Post-Covid bump.
See below for the White Paper:
A Detailed Study of Patients with Long-Haul COVID : An Analysis of Private Healthcare Claims
I call BS. Note the title itself: They are using a study of 'health claims' without study of the patients' actual health to draw conclusions. The devil's in the details:
To perform this analysis, FAIR Health drew on longitudinal data from its database of over 34 billion private healthcare claim records from 2002 to the present. The nation’s largest such repository, it is growing by over 2 billion claim records per year. All patients in the longitudinal dataset who had been diagnosed with COVID-19 from February to December 2020 were included, except for those with certain preexisting conditions (such as cancer and chronic kidney disease) that might have acted as confounders. The remaining 1,959,982 patients [i.e. patient records] were studied for their case characteristics, such as age, gender and reaction to COVID-19 (i.e., asymptomatic, symptomatic, hospitalization, loss of taste or smell only). They [their records] were further studied for the prevalence of post-COVID conditions 30 days or more after their initial diagnosis with COVID-19. Their post-COVID conditions [RECORDS!!!] were analyzed, with the most common conditions identified. Particular attention was given to age and gender, mental health conditions and death.How scientific of them. /s Of course, this is all 100% dependent upon the accuracy of digital health records, claims data and diagnoses (let that sink in).
Anyone with an open mind can discern some enlightenment from this 'white paper' - confirmation bias being what it is - but there are fewer details on these patients via this 'study' (nothing more than a data mining project) than on those who've suffered adverse effects from the so-called 'vaccines'.
We all know how the vaxxers treat THOSE "anecdotal" reports...
Oh, and read the line in the SFGate piece about the study NOT being 'peer reviewed' if you're a FReeper reading my comment and getting emotional...
My wife had a moderate bout with covid, and has been diagnosed with new lung damage, including COPD.